217 related articles for article (PubMed ID: 7795143)
1. Is haemophilia prophylaxis achievable in the context of self-sufficiency?
Nilsson IM
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S71-5. PubMed ID: 7795143
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis for severe haemophilia: clinical and economical issues.
Fischer K; Van Den Berg M
Haemophilia; 2003 Jul; 9(4):376-81. PubMed ID: 12828671
[TBL] [Abstract][Full Text] [Related]
3. How will immune tolerance protocols affect self-sufficiency goals?
Brackmann HH
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S77-9. PubMed ID: 7795144
[TBL] [Abstract][Full Text] [Related]
4. The orthopaedic status of severe haemophiliacs in Spain.
Aznar JA; Magallón M; Querol F; Gorina E; Tusell JM
Haemophilia; 2000 May; 6(3):170-6. PubMed ID: 10792475
[TBL] [Abstract][Full Text] [Related]
5. Economic issues in European self-sufficiency.
Szucs TD
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S51-5. PubMed ID: 7795140
[TBL] [Abstract][Full Text] [Related]
6. [Prophylactic treatment with clotting factor to prevent joint damage in patients with severe haemophilia: costs versus benefits].
Roosendaal G; Lafeber FP
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2606-8. PubMed ID: 18161260
[TBL] [Abstract][Full Text] [Related]
7. The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP.
Berntorp E
Baillieres Clin Haematol; 1996 Jun; 9(2):259-71. PubMed ID: 8800504
[TBL] [Abstract][Full Text] [Related]
8. Paediatric care of the child with haemophilia.
Ljung R
Haemophilia; 2002 May; 8(3):178-82. PubMed ID: 12010407
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis for hemophilia: state of the art or state of confusion?
Gruppo RA
J Pediatr; 1998 Jun; 132(6):915-7. PubMed ID: 9627577
[No Abstract] [Full Text] [Related]
10. [Prevention of joint damage in hemophilic children with early prophylaxis].
Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
[TBL] [Abstract][Full Text] [Related]
11. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.
Nilsson IM; Berntorp E; Löfqvist T; Pettersson H
J Intern Med; 1992 Jul; 232(1):25-32. PubMed ID: 1640190
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic factor replacement in hemophilia.
Carcao MD; Aledort L
Blood Rev; 2004 Jun; 18(2):101-13. PubMed ID: 15010149
[TBL] [Abstract][Full Text] [Related]
13. Unresolved issues in prophylaxis.
Brown SA; Aledort LM; Astermark J; Berntorp E; van den Berg M; Blanchette V; Donfield S; Gringeri A; Hilgartner M; Kulkarni R; Leissinger C; Negrier C; Nuss R; Petterson H; Petrini P; Poulios N; Schramm W;
Haemophilia; 2002 Nov; 8(6):817-21. PubMed ID: 12410654
[No Abstract] [Full Text] [Related]
14. Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy.
Giampaolo A; Abbonizio F; Puopolo M; Arcieri R; Mannucci PM; ; Hassan HJ; Accorsi A; Ettorre PC; Schiavoni M; Palareti G; Rodorigo G; Valdré L; Amaddii G; Billio A; Notarangelo L; Iannacaro P; Muleo P; Biasioli C; Rossi V; Alatri A; Testa S; Vincenzi D; Scapoli G; Morfini M; Molinari AC; Lapecorella M; Mariani G; Baudo F; Caimi MT; Federici AB; Gringeri A; Mannucci PM; Santagostino E; Marietta M; Coppola A; Di Minno G; Perricone C; Schiavulli M; Miraglia E; Rocino A; Zanon E; Gagliano F; Mancuso G; Siragusa S; Rivolta F; Tagliaferri A; Gamba G; Iorio A; Oliovecchio E; Dragani A; Arbasi MC; Albertini P; Mancino A; Lombardo VT; Latella C; D'Incà M; Landolfi Raffaele ; Biondo Francesca ; Mazzucconi MG; Santoro Cristina ; Mameli AL; Piseddu G; Schinco PC; Messina M; Rossetti G; Barillari G; Feola G; Franchini M; Gandini G; Castaman G; Rodeghiero F
Transfus Med; 2011 Aug; 21(4):280-4. PubMed ID: 21733006
[No Abstract] [Full Text] [Related]
15. [Results of a cooperative programme of profilactic treatment for haemophilia A and B (author's transl)].
Sangre (Barc); 1978; 23(5B):780-92. PubMed ID: 725718
[No Abstract] [Full Text] [Related]
16. Epidemiological survey of haemophiliacs with inhibitors in France: orthopaedic status, quality of life and cost--the 'Statut Orthopédique des Patients Hémophiles' avec Inhibiteur study.
Stieltjes N; Torchet MF; Misrahi L; Roussel-Robert V; Lambert T; Guérois C; Bertrand MA; Briquel ME; Borel-Derlon A; Dirat G
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):4-11. PubMed ID: 20527720
[TBL] [Abstract][Full Text] [Related]
17. Experience with prophylaxis in Sweden.
Nilsson IM
Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738
[No Abstract] [Full Text] [Related]
18. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia.
van den Berg HM; Fischer K; Mauser-Bunschoten EP; Beek FJ; Roosendaal G; van der Bom JG; Nieuwenhuis HK
Br J Haematol; 2001 Mar; 112(3):561-5. PubMed ID: 11260054
[TBL] [Abstract][Full Text] [Related]
19. Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres.
Nerich V; Tissot E; Faradji A; Demesmay K; Bertrand MA; Lorenzini JL; Briquel ME; Pouzol P; Woronoff-Lemsi MC
Pharm World Sci; 2008 Jun; 30(3):287-92. PubMed ID: 18085428
[TBL] [Abstract][Full Text] [Related]
20. Current issues in prophylactic therapy for persons with hemophilia.
Dunn AL; Abshire TC
Acta Haematol; 2006; 115(3-4):162-71. PubMed ID: 16549891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
